Directional selection at the pfmdr1, pfcrt, pfubp1, and pfap2mu loci of Plasmodium falciparum in Kenyan children treated with ACT
- PMID: 24994911
- PMCID: PMC4241946
- DOI: 10.1093/infdis/jiu358
Directional selection at the pfmdr1, pfcrt, pfubp1, and pfap2mu loci of Plasmodium falciparum in Kenyan children treated with ACT
Abstract
Background: The efficacy of artemisinin-based combination therapy (ACT) for Plasmodium falciparum malaria may be threatened by parasites with reduced responsiveness to artemisinins. Among 298 ACT-treated children from Mbita, Kenya, submicroscopic persistence of P. falciparum on day 3 posttreatment was associated with subsequent microscopically detected parasitemia at days 28 or 42.
Methods: DNA sequences of resistance-associated parasite loci pfcrt, pfmdr1, pfubp1, and pfap2mu were determined in the Mbita cohort before treatment, on days 2 and 3 after initiation of treatment, and on the day of treatment failure.
Results: Parasites surviving ACT on day 2 or day 3 posttreatment were significantly more likely than the baseline population to carry the wild-type haplotypes of pfcrt (CVMNK at codons 72-76; P < .001) and pfmdr1 (NFD at codons 86, 184, 1246; P < .001). In contrast, variant alleles of the novel candidate resistance genes pfap2mu (S160N/T; P = .006) and pfubp-1 (E1528D; P < .001) were significantly more prevalent posttreatment. No genetic similarities were found to artemisinin-tolerant parasites recently described in Cambodia.
Conclusions: Among treated children in western Kenya, certain P. falciparum genotypes defined at pfcrt, pfmdr1, pfap2mu, and pfubp1 more often survive ACT at the submicroscopic level, and contribute to onward transmission and subsequent patent recrudescence.
Keywords: artemisinin; drug resistance; genetics; malaria.
© The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America.
Figures
Similar articles
-
Characterization of pfmdr1, pfcrt, pfK13, pfubp1, and pfap2mu in Travelers Returning from Africa with Plasmodium falciparum Infections Reported in China from 2014 to 2018.Antimicrob Agents Chemother. 2021 Jun 17;65(7):e0271720. doi: 10.1128/AAC.02717-20. Epub 2021 Jun 17. Antimicrob Agents Chemother. 2021. PMID: 33903109 Free PMC article.
-
Selection of Plasmodium falciparum pfcrt and pfmdr1 polymorphisms after treatment with artesunate-amodiaquine fixed dose combination or artemether-lumefantrine in Liberia.Malar J. 2016 Sep 5;15(1):452. doi: 10.1186/s12936-016-1503-3. Malar J. 2016. PMID: 27596849 Free PMC article. Clinical Trial.
-
Prevalence of Plasmodium falciparum delayed clearance associated polymorphisms in adaptor protein complex 2 mu subunit (pfap2mu) and ubiquitin specific protease 1 (pfubp1) genes in Ghanaian isolates.Parasit Vectors. 2018 Mar 12;11(1):175. doi: 10.1186/s13071-018-2762-3. Parasit Vectors. 2018. PMID: 29530100 Free PMC article.
-
Increased prevalence of the Plasmodium falciparum Pfmdr1 86N genotype among field isolates from Franceville, Gabon after replacement of chloroquine by artemether-lumefantrine and artesunate-mefloquine.Infect Genet Evol. 2011 Mar;11(2):512-7. doi: 10.1016/j.meegid.2011.01.003. Epub 2011 Jan 17. Infect Genet Evol. 2011. PMID: 21251998
-
In vitro selection of Plasmodium falciparum Pfcrt and Pfmdr1 variants by artemisinin.Malar J. 2016 Jul 22;15(1):381. doi: 10.1186/s12936-016-1443-y. Malar J. 2016. PMID: 27449110 Free PMC article.
Cited by
-
Deaggregation of mutant Plasmodium yoelii de-ubiquitinase UBP1 alters MDR1 localization to confer multidrug resistance.Nat Commun. 2024 Feb 27;15(1):1774. doi: 10.1038/s41467-024-46006-3. Nat Commun. 2024. PMID: 38413566 Free PMC article.
-
Emergence, transmission dynamics and mechanisms of artemisinin partial resistance in malaria parasites in Africa.Nat Rev Microbiol. 2024 Feb 6. doi: 10.1038/s41579-024-01008-2. Online ahead of print. Nat Rev Microbiol. 2024. PMID: 38321292 Review.
-
In vitro delayed response to dihydroartemisinin of malaria parasites infecting sickle cell erythocytes.Malar J. 2024 Jan 4;23(1):9. doi: 10.1186/s12936-023-04819-5. Malar J. 2024. PMID: 38178227 Free PMC article.
-
The Kelch13 compartment contains highly divergent vesicle trafficking proteins in malaria parasites.PLoS Pathog. 2023 Dec 1;19(12):e1011814. doi: 10.1371/journal.ppat.1011814. eCollection 2023 Dec. PLoS Pathog. 2023. PMID: 38039338 Free PMC article.
-
Treatment Failure in a UK Malaria Patient Harboring Genetically Variant Plasmodium falciparum From Uganda With Reduced In Vitro Susceptibility to Artemisinin and Lumefantrine.Clin Infect Dis. 2024 Feb 17;78(2):445-452. doi: 10.1093/cid/ciad724. Clin Infect Dis. 2024. PMID: 38019958 Free PMC article.
References
-
- Noedl H, Se Y, Schaecher K, Smith BL, Socheat D, Fukuda MM Artemisinin Resistance in Cambodia 1 (ARC1) Study Consortium. Evidence of artemisinin-resistant malaria in western Cambodia. N Engl J Med. 2008;359:2619–20. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
